Development of a novel high-concentration galantamine formulation suitable for intranasal delivery

This publication has 35 references indexed in Scilit:

• In vivo and in vitro study of the influence of the anticholinesterase drug galantamine on motor and evacuative functions of rat gastrointestinal tract
  European Journal of Pharmacology, 2004
• Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Galantamine — a Novel Cholinergic Drug with a Unique Dual Mode of Action for the Treatment of Patients with Alzheimer's Disease
  CNS Drug Reviews, 2002
• Intranasal Delivery of Morphine
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase Inhibitors
  Clinical Pharmacokinetics, 2002
• Galantamine
  Drugs, 2000
• Review of the acetylcholinesterase inhibitor galanthamine
  Expert Opinion on Investigational Drugs, 2000
• Allosteric Modulation of Nicotinic Receptors as a Treatment Strategy for Alzheimer’s Disease
  Dementia and Geriatric Cognitive Disorders, 2000
• Evidence-based pharmacotherapy of Alzheimer's disease
  International Journal of Neuropsychopharmacology, 1999
• Nasal spray vs oral administration of bromocriptine: Pharmacology and effect on serum prolactin in puerperal women
  Journal of Endocrinological Investigation, 1996